000 01294 a2200361 4500
005 20250517234210.0
264 0 _c20190819
008 201908s 0 0 eng d
022 _a1557-7422
024 7 _a10.1089/hum.2017.251
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMorgan, Michael A
245 0 0 _aChimeric Antigen Receptor T Cells: Extending Translation from Liquid to Solid Tumors.
_h[electronic resource]
260 _bHuman gene therapy
_c10 2018
300 _a1083-1097 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aGene Editing
650 0 4 _aGenetic Engineering
650 0 4 _aGenetic Vectors
_xgenetics
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aReceptors, Antigen, T-Cell
_xgenetics
650 0 4 _aReceptors, Chimeric Antigen
_xgenetics
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTranslational Research, Biomedical
700 1 _aSchambach, Axel
773 0 _tHuman gene therapy
_gvol. 29
_gno. 10
_gp. 1083-1097
856 4 0 _uhttps://doi.org/10.1089/hum.2017.251
_zAvailable from publisher's website
999 _c28777650
_d28777650